NCT04119024 2026-03-17
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Phase 1 Recruiting
Clinical Trials
291 trialsNCT07092514 2026-03-17
Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)
Washington University School of Medicine
Phase 2 Recruiting
NCT03360890 2026-03-13
iPRIME
University of Chicago
Phase 2 Active not recruiting
NCT03753919 2026-03-11
DUTHY
Grupo Espanol de Tumores Neuroendocrinos
Phase 2 Terminated
NCT03570021 2026-03-06
ESTIMABL3
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Active not recruiting
NCT07447089 2026-03-04
EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study
Università Cattolica di Milano
Phase NA Recruiting
NCT03420963 2026-03-03
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT06554652 2026-02-27
Selective Neck Dissection Versus Modified Neck Dissection in PTC
Fudan University
Phase 3 Recruiting
NCT06558981 2026-02-27
Adjuvant Radiotherapy in High Risk Locally Advanced DTC
Fudan University
Phase 3 Recruiting
NCT07193186 2026-02-27
Anlotinib and Benmelstobart in DTC
Fudan University
Phase 2 Not yet recruiting
NCT07436455 2026-02-27
NISDETECT
Ankara University
Phase NA Recruiting
NCT07438847 2026-02-27
177Lu-CTR-FAPI for the Treatment of Thyroid Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1 Recruiting
NCT07406087 2026-02-25
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Kaiser Permanente
Phase NA Not yet recruiting
NCT07433283 2026-02-25
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Sichuan Enray Pharmaceutical Sciences Company
Phase 1/2 Recruiting
NCT07434206 2026-02-25
Safety and Efficacy of Dexmedetomidine in Controlling Hemodynamics During Resection of Active Thyroid Secreting Tumors
South Egypt Cancer Institute
Phase 2/3 Active not recruiting
NCT05229341 2026-02-23
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
City of Hope Medical Center
Phase NA Recruiting
NCT06007924 2026-02-19
A Study of Avutometinib and Defactinib in People With Thyroid Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT06073223 2026-02-17
Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer
University of Michigan Rogel Cancer Center
Phase NA Completed
NCT06465017 2026-02-17
ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer
The First Affiliated Hospital of Xiamen University
Phase NA Terminated
NCT07405320 2026-02-12
A Brief Video Intervention to Improve Patient Outcomes Following Radioiodine Treatment
University of Auckland, New Zealand
Phase NA Not yet recruiting
NCT04104529 2026-02-05
BCB RIV
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Recruiting
NCT04459273 2026-02-05
FAPI PET RDRC
Jonsson Comprehensive Cancer Center
Phase 1 Active not recruiting
NCT04916990 2026-02-05
Improving Care for Rural Patients With Solid Tumors
University of Colorado, Denver
Phase NA Recruiting
NCT06984991 2026-02-03
FNA inadequacy
Assiut University
Phase NA Recruiting
NCT07370675 2026-01-27
Active Surveillance for Bethesda IV Thyroid Nodules
Rigshospitalet, Denmark
Phase NA Recruiting
NCT07225309 2026-01-26
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Not yet recruiting
NCT04593277 2026-01-23
Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study
Fred Hutchinson Cancer Center
Phase NA Completed
NCT06853925 2026-01-16
Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients
Georgetown University
Phase NA Recruiting
NCT03181100 2026-01-09
Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT07218315 2026-01-09
Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
M.D. Anderson Cancer Center
Phase NA Not yet recruiting
NCT06980103 2026-01-08
Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer
Georgetown University
Phase NA Recruiting
NCT06961084 2026-01-07
Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
University of California, San Francisco
Phase 2 Recruiting
NCT05119296 2025-12-22
Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
Stanford University
Phase 2 Active not recruiting
NCT07274605 2025-12-10
Comparing the Therapeutic Efficacy of Extended Isthmusectomy Versus Total Thyroidectomy for Isthmus Tumors of the Thyroid
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Not yet recruiting
NCT07274670 2025-12-10
BPSS-DEX
Udayana University
Phase NA Completed
NCT03647358 2025-12-02
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT06458036 2025-11-25
RAISE
Children's Hospital of Philadelphia
Phase 2 Recruiting
NCT04589624 2025-11-21
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT04061980 2025-11-19
Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer
Providence Health & Services
Phase 2 Active not recruiting
NCT06959511 2025-11-19
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT07235553 2025-11-19
Non-inferiority Investigation to Evaluate the Efficacy and Safety of the Ultrasonic Surgical System
Ezisurg Medical Co. Ltd.
Phase NA Completed
NCT07235566 2025-11-19
MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC
Fudan University
Phase 2 Recruiting
NCT05783323 2025-11-14
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Children's Hospital of Philadelphia
Phase 2 Recruiting
NCT04759911 2025-11-13
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04463719 2025-11-10
AIM2: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid
University of Florida
Phase NA Completed
NCT06902376 2025-11-05
NEO-COMBATXL
UNC Lineberger Comprehensive Cancer Center
Phase 1 Recruiting
NCT02713269 2025-10-30
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT05999630 2025-10-28
Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer
Vanderbilt University Medical Center
Phase 3 Recruiting
NCT01709292 2025-10-27
Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04693377 2025-10-27
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
M.D. Anderson Cancer Center
Phase NA Recruiting